X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (22) 22
hygiene (22) 22
medical or veterinary science (22) 22
preparations for medical, dental, or toilet purposes (16) 16
specific therapeutic activity of chemical compounds ormedicinal preparations (15) 15
general tagging of cross-sectional technologies spanning over several sections of the ipc (13) 13
general tagging of new technological developments (13) 13
investigating or analysing materials by determining theirchemical or physical properties (13) 13
measuring (13) 13
physics (13) 13
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (13) 13
technologies for adaptation to climate change (13) 13
technologies or applications for mitigation or adaptation againstclimate change (13) 13
testing (13) 13
animals (10) 10
pharmacology & pharmacy (9) 9
botulinum toxin (8) 8
index medicus (8) 8
identification (7) 7
mice (7) 7
rats (7) 7
toxicology (7) 7
botulinum toxins, type a - pharmacology (6) 6
cmap (6) 6
diagnosis (6) 6
female (6) 6
mice, inbred icr (6) 6
surgery (6) 6
dose-response relationship, drug (5) 5
a2ntx (4) 4
grip strength (4) 4
muscle, skeletal - drug effects (4) 4
neurotoxin (4) 4
ntx (4) 4
rats, wistar (4) 4
tetanus (4) 4
action potentials - drug effects (3) 3
axonal transport (3) 3
male (3) 3
modulation (3) 3
neurons (3) 3
neurons - drug effects (3) 3
neurotoxins (3) 3
neurotoxins - pharmacology (3) 3
synaptic transmission - drug effects (3) 3
assay (2) 2
bioassay (2) 2
botulinum antitoxin - pharmacology (2) 2
botulinum toxins - toxicity (2) 2
botulinum toxins, type a - toxicity (2) 2
chemistry (2) 2
colchicine (2) 2
colchicine - pharmacology (2) 2
efficacy (2) 2
evoked ipsc and epsc (2) 2
focal electrical stimulation (2) 2
humans (2) 2
intramuscular injection (2) 2
lethal dose 50 (2) 2
ll toxin (2) 2
metallurgy (2) 2
miniature ipsc and epsc (2) 2
mouse ip ld (2) 2
mouse ip ld 50 (2) 2
mouse ip ld50 (2) 2
muscle strength - drug effects (2) 2
muscle, skeletal - physiology (2) 2
neurons - physiology (2) 2
neuroscience (2) 2
neurosciences (2) 2
neurotomy (2) 2
organic chemistry (2) 2
patch-clamp techniques (2) 2
peptides (2) 2
presynaptic terminals - drug effects (2) 2
protein-receptor (2) 2
proteins (2) 2
rats, sprague-dawley (2) 2
seizures (2) 2
spinal cord (2) 2
spinal cord - drug effects (2) 2
spinal nerve ending (2) 2
synaptic-transmission (2) 2
synaptotagmin (2) 2
terminals (2) 2
therapeutics. pharmacology (2) 2
therapy (2) 2
transmitter release (2) 2
a toxin (1) 1
a2 type neurotoxin (1) 1
amino acid sequence (1) 1
amplitudes (1) 1
amygdala - drug effects (1) 1
analysis (1) 1
anticonvulsants - pharmacology (1) 1
antitoxins - analysis (1) 1
antitoxins - pharmacology (1) 1
beer (1) 1
behavioural (1) 1
biochemistry (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (43) 43
French (17) 17
German (10) 10
Japanese (8) 8
Spanish (2) 2
Danish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Pharmacological Sciences, ISSN 1347-8613, 2012, Volume 118, Issue 1, pp. 33 - 42
Journal Article
Frontiers in Neurology, ISSN 1664-2295, 2014, Volume 5, p. 98
Because of its unique ability to exert long-lasting synaptic transmission blockade, botulinum neurotoxin A (BoNT/A) is used to treat a wide variety of... 
Spinal cord | Botulinum neurotoxin | Axonal transport | Central effects | SNAP-25 | central effects | axonal transport | spinal cord | botulinum neurotoxin | NEUROSCIENCES | CLINICAL NEUROLOGY | Spinal Cord | Botulinum Neurotoxin
Journal Article
The Journal of Physiology, ISSN 0022-3751, 02/2013, Volume 591, Issue 4, pp. 1031 - 1043
Journal Article
Toxicon, ISSN 0041-0101, 2008, Volume 51, pp. 19 - 19
Background: Researchers at the consumer group Public Citizen said that Botox(BTX) should carry a black box warning. They reviewed adverse event reports... 
Spread | NTX | BTX
Journal Article
Toxicon, ISSN 0041-0101, 2008, Volume 51, pp. 22 - 22
Introduction: Botulinum toxin is used for various indications in the world; adverse reactions appear to be related to the spread of the toxin to areas distant... 
LL toxin | A2NTX | Grip strength
Journal Article
Toxicon, ISSN 0041-0101, 2008, Volume 51, pp. 15 - 15
Introduction: The botulinum neurotoxin type A complex is the drug of choice for neurological disorders in the world. Botulinum toxin has the ability to inhibit... 
Mouse phrenic nerve–hemidiaphragm | NTX
Journal Article
Toxicon, ISSN 0041-0101, 2008, Volume 51, pp. 21 - 22
Introduction: In some patients undergoing continuous botulinum toxin treatment, the treatment response reduces, although the frequency is low. This may be... 
CMAP | Neutralizing antibody | NTX
Journal Article
Toxicon, ISSN 0041-0101, 2008, Volume 51, pp. 16 - 16
Introduction: Several papers have reported that patients undergoing frequent inoculations with therapeutic botulinum toxin preparations may show a reduced... 
Immunogenicity | LL toxin | A2NTX
Journal Article
Toxicon, ISSN 0041-0101, 2008, Volume 51, pp. 21 - 21
The treatment response reduces in some patients undergoing botulinum toxin treatment, and their sera may contain antibodies. The standard method of detecting... 
CMAP
Journal Article
Toxicon, ISSN 0041-0101, 2008, Volume 51, pp. 12 - 12
Introduction: The botulinum neurotoxin complex type A1 (A1LL) is widely used in the world for neurological disorders. Improved safety is hoped for when... 
ED50 | SD50 | NTX | CMAP
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.